Literature DB >> 14529856

Patients with steroid refractory acute vascular rejection develop agonistic antibodies targeting angiotensin II type 1 receptor.

D Dragun1, J H Bräsen, C Schönemann, L Fritsche, K Budde, H-H Neumayer, F C Luft, G Wallukat.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14529856     DOI： 10.1016/s0041-1345(03)00680-8

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

Review 1.  Receptor-activating autoantibodies and disease: preeclampsia and beyond.

Authors:  Yang Xia; Rodney E Kellems
Journal:  Expert Rev Clin Immunol       Date:  2011-09       Impact factor: 4.473

Review 2.  Agonist autoantibodies against the angiotensin AT1 receptor in renal and hypertensive disorders.

Authors:  Thomas Walther; Holger Stepan
Journal:  Curr Hypertens Rep       Date:  2007-04       Impact factor: 4.592

Review 3.  Antibody-mediated rejection after kidney transplantation in children; therapy challenges and future potential treatments.

Authors:  Massimiliano Bertacchi; Paloma Parvex; Jean Villard
Journal:  Clin Transplant       Date:  2022-02-16       Impact factor: 3.456

Review 4.  Antibodies against Angiotensin II Type 1 and Endothelin 1 Type A Receptors in Cardiovascular Pathologies.

Authors:  Giovanni Civieri; Laura Iop; Francesco Tona
Journal:  Int J Mol Sci       Date:  2022-01-15       Impact factor: 5.923

5.  Intimal Arteritis and Microvascular Inflammation Are Associated With Inferior Kidney Graft Outcome, Regardless of Donor-Specific Antibodies.

Authors:  Marek Novotny; Petra Hruba; Martin Kment; Ludek Voska; Katerina Kabrtova; Antonij Slavcev; Ondrej Viklicky
Journal:  Front Med (Lausanne)       Date:  2021-12-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.